Current Opinion in Urology

Papers
(The TQCC of Current Opinion in Urology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Differences in lasers and laser technologies: what does a clinician need to know?44
Measuring kidney stone volume – practical considerations and current evidence from the EAU endourology section31
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis25
Is there a role for neoadjuvant therapies followed by radical cystectomy in oligometastatic bladder cancer?21
The functioning and the complication rate of extreme long existing urinary diversions20
Active surveillance for non-muscle-invasive bladder cancer: fallacy or opportunity?20
Digital health innovations in urology: telemedicine, wearables, and mobile applications – a systematic review of literature19
Polygenic risk score in prostate cancer16
Adverse events of systemic immune-based combination therapies in the first-line treatment of patients with metastatic renal cell carcinoma: systematic review and network meta-analysis16
Current clinical evidence in intrarenal temperature, pressure and suction during retrograde intrarenal surgery: a review of literature16
Association and risk of metabolic syndrome and kidney stone disease: outcomes from a systematic review and meta-analysis16
Minimizing overtreatment and maximizing oncologic outcomes in upper tract urothelial carcinoma16
Update on penile sparing surgery for penile cancer15
Current developments in prehabilitation in urologic oncology14
Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker14
Management of upper urinary tract problems after radical cystectomy for urothelial carcinoma: tips and tricks13
Gaps in knowledge and recurrent urinary tract infections in women13
Kidney cancer management 3.0: can artificial intelligence make us better?13
Artificial urinary sphincter: recent developments and the way forward13
The role of geriatric assessment in the care of older adults undergoing urologic cancer surgery13
Long-term outcome of urethral and genital reconstruction in hypospadias and exstrophy-epispadias complex12
Electrosurgery or laser for benign prostatic enlargement: trumpcard or pitfalls11
The role of cytoreductive nephrectomy in the immuno-oncological therapy era11
Use of genomic markers to improve epidemiologic and clinical research in urology11
Artificial intelligence in prostate histopathology: where are we in 2021?11
Orthotopic urinary diversions after radical cystectomy for bladder cancer: lessons learned last decade11
Editorial introductions11
Implications and effects of COVID-19 on diagnosis and management of prostate cancer10
Research on texture images and radiomics in urology: a review of urological MR imaging applications10
Immunotherapy combinations for metastatic castration-resistant prostate cancer – failed trials and future aspects10
Editorial introduction10
Modern surgical treatment of azoospermia10
Research frontiers in urology10
Emerging systemic treatment for metastatic castration-resistant prostate cancer: a review of recent randomized controlled trials9
Renal cell carcinoma with inferior vena cava thrombus: did we make progress in oncologic outcomes and complications?9
Paediatric stone management: innovations and standards9
Device-assisted intravesical chemotherapy treatment for nonmuscle invasive bladder cancer: 2022 update8
Comparative performance of the different orthotopic urinary diversions8
Endemic statistical paradoxes in epidemiologic studies distort knowledge on prostate cancer: mitigation and caution of fallacies in prostate cancer causal epidemiological studies8
Drug instillation in the management of urinary tract urothelial carcinoma8
Lithotripsy devices for percutaneous nephrolithotomy (PNL) – new developments8
Implications of DNA damage repair alterations for the management of prostate cancer8
The future of laser technology in kidney stones8
Technical advances in nerve-sparing and continence preservation7
Editorial: Standard and future in the treatment of renal cell carcinoma7
Editorial introductions7
Footprints in the scan: reducing the carbon footprint of diagnostic tools in urology7
The adverse impact of COVID-19 on men's health7
Editorial: Impact of coronavirus disease 2019 on urological healthcare7
Percutaneous management of caliceal diverticula: a narrative review7
Phantom sensation in genital gender-affirming surgery: a narrative review7
Changes in practice patterns of nephrolithiasis in the era of the coronavirus disease 2019 pandemic: a review7
Editorial: Medical, technical and functional aspect of various types of urinary diversion7
Extramammary Paget's Disease of genitourinary origin7
Retrograde intrarenal surgery for stones associated with renal anomalies: caliceal diverticulum, horseshoe kidney, medullary sponge kidney, megacalycosis, pelvic kidney, uretero-pelvic junction obstru7
The impact of COVID-19 on urology office visits and adoption of telemedicine services7
Thulium fiber laser in urology: physics made simple6
Inflammation and kidney stones: cause and effect?6
Plant-based diets, animal agriculture, and the connection with urological and planetary health6
Current evidence for suction in endourological procedures: comprehensive review of literature6
Adjuvant treatment for renal cell carcinoma: current status and future6
Best nonsurgical managements of acute urinary retention: what's new?6
The role of innovations in advancing urologic oncologic patient care6
Patient-reported outcomes and health-related quality of life after urinary diversions6
Non-invasive central nervous system stimulation to improve bladder and pelvic floor function in the aging population5
Current role of salvage radiotherapy in oligometastatic prostate cancer at the time of recurrence5
Optimal systemic therapy in men with low-volume prostate cancer5
Advanced sperm tests and impact on clinical male factor management5
Urinary incontinence in older adults – enhancing care and future research5
Testicular cancer with small metastatic burden: optimal approach in 20245
Preclinical models for bladder cancer therapy research5
Role of cytoreductive surgery in the era of immunotherapy5
Association between male infertility and prostate cancer: a systematic review and meta-analysis: erratum5
Optimal combination therapy for metastatic hormone-sensitive prostate cancer: new evidence, challenges and unanswered questions5
Editorial introductions5
Transurethral resection of bladder cancer with or without fluorescence4
Patient education and surgical decision-making in genital gender-affirming surgery4
Editorial introductions4
Editorial introductions4
The use of MRI in urothelial carcinoma4
Postoperative medical treatment of lower urinary tract symptoms after benign prostatic hyperplasia surgery. Are we underestimating the problem?4
Focal therapy: definition and rationale4
Salvage lymphadenectomy after primary therapy with curative intent for prostate cancer4
En bloc resection of large bladder tumor: is it feasible and reasonable?4
The environmental impacts of anesthesia4
Update on robotic cystectomy4
Robotic-assisted retroperitoneal lymph node dissection for testicular cancer4
Urinary diversions for benign and oncologic indications: what did we learn about short term complications in the last 24 months?4
Update on the management of complex strictures of the bulbar urethra4
Sustainable practices in hospital and operating theaters4
Prevention, diagnosis, and treatment of urolithiasis in geriatric patients - differences, similarities and caveats in comparison to the general population4
Editorial: Salvage therapy in uro-oncology4
Nerve-sparing technique in RPLND for testicular cancer4
Editorial introductions4
Progression-free survival is an adequate endpoint for clinical trials of locally advanced and metastatic urothelial carcinoma4
Imaging in stone diagnosis and surgical planning3
Retrograde intrarenal surgery: laser showdown (Ho:YAG vs thulium fiber laser)3
Organ-sparing treatment for T1 and T2 penile cancer: an updated literature review3
Surgical management of testicular cancer with limited retroperitoneal disease3
Adrenal functional imaging – which marker for which indication?3
Editorial: genetics in urology3
Micropapillary bladder cancer: an evolving biology3
Radioguided surgery for lymph node metastases in prostate cancer3
Overview of current applications and trends in artificial intelligence for cystoscopy and transurethral resection of bladder tumours3
Upper tract urothelial carcinoma: epidemiology, presentation, and high-risk endemic populations3
Antegrade ejaculation preservation in surgical treatment for benign prostatic hyperplasia: quest for balance between voiding and sexual function3
The role of MRI in muscle-invasive bladder cancer: an update from the last two years3
Rising significance of antibiotic stewardship in urology and urinary tract infections – a rapid review3
Editorial introductions3
Editorial introductions3
Definitions and unmet needs in the management of oligomestatic renal cell carcinoma in the modern era3
Thulium fiber laser in endourology: current clinical evidence3
Genetics of testicular cancer: a review3
Metabolic evaluation: is there really a future?3
Advances in preclinical assessment of therapeutic targets for bladder cancer precision medicine3
Overlooked and underserved: how healthcare fails men in the pursuit of equity3
Advancing men's health: insights and innovations3
Metastasis-directed treatment in kidney cancer3
RNA-based urinary assays for non-muscle invasive bladder cancer3
Diagnostic evaluation for adrenal tumors – What does the urologist need to know about endocrine metabolic work up?3
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladder3
Detection of urological cancers by the signature of organic volatile compounds in urine, from dogs to electronic noses3
Current evidence on local therapy in oligometastatic prostate cancer3
Gold standard nephroureterectomy, chemoprophylaxis and surveillance in upper tract urothelial carcinoma3
0.13960599899292